Cargando…
Expression and clinical significance of PD-L1 and BRAF expression in nasopharyngeal carcinoma
BACKGROUND: The prognostic value of programmed death-ligand 1 (PD-L1) and BRAF expression in nasopharyngeal carcinoma (NPC) is not well-defined. In this study we investigated alterations in PD-L1, BRAF and EGFR by using immunohistochemistry analysis in a cohort of consecutively enrolled NPC patients...
Autores principales: | Cao, Yabing, Chan, Kin Iong, Xiao, Gungli, Chen, Yanqun, Qiu, Xibin, Hao, Hu, Mak, Sao Chi, Lin, Tongyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6819586/ https://www.ncbi.nlm.nih.gov/pubmed/31664962 http://dx.doi.org/10.1186/s12885-019-6276-y |
Ejemplares similares
-
Influence of gender and age on the survival of patients with nasopharyngeal carcinoma
por: Xiao, Guangli, et al.
Publicado: (2013) -
Efficacy and Safety of Crizotinib among Chinese EML4-ALK-Positive, Advanced-Stage Non-Small Cell Lung Cancer Patients
por: Cao, Yabing, et al.
Publicado: (2014) -
Effectiveness and safety of osimertinib in patients with metastatic EGFR T790M-positive NSCLC: An observational real-world study
por: Cao, Yabing, et al.
Publicado: (2019) -
Cytomembranic PD-L1 expression in locoregionally advanced nasopharyngeal carcinoma
por: Zheng, Linfeng, et al.
Publicado: (2017) -
The prognostic significance of PD-L1 and PD-1 expression in patients with nasopharyngeal carcinoma: a systematic review and meta-analysis
por: Huang, Zi-Lu, et al.
Publicado: (2019)